Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2010
05/06/2010WO2010049073A1 1,1,1-trifluoro-3-amino-3-heteroaryl-2-propanoles, a process for their production and their use as anti-inflammatory agents
05/06/2010WO2010027746A3 Hedgehog pathway modulators
05/06/2010WO2009007098A8 Isothiazole and pyrazole derivatives as fungicides
05/06/2010US20100113796 Indole derivatives as s1p1 receptor
05/06/2010US20100113794 Method for producing amide compound
05/06/2010US20100113785 intermediates for enantiomerically pure analogs having silyl or alkyl groups at C4 position; organometallic nucleophile or Grignard and an silyl or alkyl acyl halide reacted with nicotine; oxidation and deacylation to 4-hydroxy; modulate nicotinic acetylcholine receptors; Alzheimer's, Parkinson's
05/06/2010US20100113784 Process for preparing crystalline aripiprazole
05/06/2010US20100113782 Diacylglycerol Acyltransferase Inhibitors
05/06/2010US20100113777 INDOLE DERIVATIVES HAVING cPLA2 INHIBITING ACTIVITY AND APPLICATIONS AND PRODUCTION METHODS OF THE SAME
05/06/2010US20100113776 Pyrazole derivative
05/06/2010US20100113774 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
05/06/2010US20100113762 Apparatus and Method Using Rotary Flow Distribution Mechanisms
05/06/2010US20100113532 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
05/06/2010US20100113527 Crystalline forms of dexlansoprazole
05/06/2010US20100113526 Process for the Preparation of Esomeprazole Magnesium Dihydrate
05/06/2010US20100113524 Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety
05/06/2010US20100113523 Tryptase Enzyme Inhibiting Aminopyridines
05/06/2010US20100113522 COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY
05/06/2010US20100113516 Quinolynylmethylimidizoles as therapeutic agents
05/06/2010US20100113493 (pyrrolidin-2-yl)phenyl derivatives
05/06/2010US20100113492 Substituted Aminopyrimidines as Cholecystokinin-1 Receptor Modulators
05/06/2010US20100113475 Pyrazolylaminopyridines as inhibitors of fak
05/06/2010US20100113473 Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor
05/06/2010US20100113468 Quinazoline derivatives as kinase inhibitors
05/06/2010US20100113467 Organic Compounds
05/06/2010US20100113465 7-azaspiro[3.5]nonane-7-carboxamide compounds
05/06/2010US20100113464 Novel pyridazine derivatives
05/06/2010US20100113462 Substituted benzoylamino-indan-2-carboxylic acids and related compounds
05/06/2010US20100113444 Prolyl hydroxylase inhibitors
05/06/2010US20100113438 Class of histone deacetylase inhibitors
05/06/2010US20100113421 Non-nucleoside reverse transcriptase inhibitors
05/06/2010US20100113419 Cgrp receptor antagonists
05/06/2010US20100113414 Thiazolyl-dihydro-indazoles
05/06/2010US20100113411 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
05/06/2010US20100113405 Methylindazole modulators of 5-ht3 receptors
05/06/2010US20100112708 Methods and Mixtures Pertaining to Analyte Determination Using Electrophilic Labeling Reagents
05/06/2010US20100111900 Heterocyclic antiviral compounds
05/06/2010CA2742007A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
05/06/2010CA2741988A1 7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same
05/06/2010CA2741709A1 Substituted spiroamines
05/06/2010CA2741644A1 Isonicotinamide orexin receptor antagonists
05/06/2010CA2741325A1 Heterocyclic antiviral arylpyridone derivatives
05/06/2010CA2741153A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010CA2739883A1 Cyclohexane derivative and pharmaceutical use thereof
05/05/2010EP2181990A1 Piperidine derivative
05/05/2010EP2181985A1 Antiviral Agent
05/05/2010EP2181108A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
05/05/2010EP2181106A1 Process for the preparation op pantoprazole sodium and pantoprazole sodium sesquihydrate
05/05/2010EP2181105A1 N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
05/05/2010EP1615914B1 Cgrp receptor antagonists
05/05/2010EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases
05/05/2010EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors
05/05/2010EP0888345B1 Sigma-2 receptors as biomarkers of tumor cell proliferation
05/05/2010CN1930157B Silylierte carboxamide
05/05/2010CN1863779B Novel indazole derivative
05/05/2010CN1832925B New P2X7 receptor avtagonists and their use
05/05/2010CN1666983B Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest contollers and a method for using the same
05/05/2010CN101702908A Hiv-1蛋白酶抑制剂 Hiv-1 protease inhibitors
05/05/2010CN101702905A Functionally selective alpha 2C adrenoreceptor agonists
05/05/2010CN101701016A N-methyl-N-o-benzoyl aminobenzene formamide compounds as well as preparation and application thereof
05/05/2010CN101701015A Method for preparing imatinib intermediate for treating chronic granulocytic leukemia
05/05/2010CN101048382B New indole or benzimidazole derivatives
05/04/2010US7709646 For therapy of thromboembolic and/or inflammatory disorders
05/04/2010US7709642 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
05/04/2010US7709637 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi
05/04/2010US7709519 2-(1,3-Dihydro-2H-benzimidazol-2-ylidene)-1-[3-(1,2-dihydroxyethyl)phenyl]-3-(3,4,5-trifluorophenyl)propane-1,3-dione; GnRH receptor antagonism; prostate cancer, breast cancer, endometriosis, uterine leiomyoma, benign prostatic hypertrophy; good availability by oral administration
05/04/2010US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents
05/04/2010US7709503 2-chloro-6-(4-{[(3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}piperidin-1-yl)-N-methoxypyrimidine-4-carboxamide; 1-[4-(aminocarbonyl)-6-chloro-2-pyridinyl]4-piperidinyl 4-bromo-5-methyl-1H-pyrrole-2-carboxylate;
05/04/2010US7709502 For reducing levels of tumor necrosis factor alpha in mammals; 3-(1-Oxo-4-aminoisoindolin-1-yl)-3-methylpiperidine-2,6 dione; 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-5-aminoisoindoline
05/04/2010US7709500 Chemical compounds
05/04/2010US7709487 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/04/2010US7709486 antiviral compounds 1,4,8,11-tetraazacyclotetradecane derivatives for against HIV-infected cells, to inhibit the binding by the natural ligand to its chemokine receptor; viricides
05/04/2010US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/04/2010US7709479 Quinazoline derivatives and their use as pharmaceuticals
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
05/04/2010US7709476 6-Methoxy-3-(methoxymethyl)-2-methyl-4-phenylisoquinolin-1(2H)-one; treat cardiac arrhythmias
05/04/2010US7709471 Compounds
05/04/2010US7709466 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals
05/04/2010US7709263 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging; [Eu.(1-4H).H2O]Na
05/04/2010CA2453609C Bridged piperidine derivatives as melanocortin receptor agonists
05/04/2010CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
05/04/2010CA2437767C Heterocyclic inhibitors of erk2 and uses thereof
05/04/2010CA2414200C Variolin derivatives as anti-cancer agents
05/04/2010CA2399196C Pyrimidine compounds
05/04/2010CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/04/2010CA2347981C Process for the manufacturing of alkaline salts of substituted sulphinyl compounds and products prepared thereby
05/04/2010CA2312087C Preparation comprising sterically hindered amines for the prevention and treatment of inflammation
04/2010
04/29/2010WO2010048477A2 Improved process for preparation of coupled products from 4-amino-3-cyanoquinolines using stabilized intermediates
04/29/2010WO2010048131A1 C-met protein kinase inhibitors
04/29/2010WO2010047372A1 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity
04/29/2010WO2010046851A1 Process for the preparation of 1- ( 3-hydroxymethylpyrid-2 -yl ) -2 -phenyl-4-methylpiperazine and mirtazapine
04/29/2010WO2010046780A2 Anti viral compounds
04/29/2010WO2010046109A1 Pyrimidine and triazine sulfonamide derivates as b1 bradykinin receptor (b1r) inhibitors for treating pain
04/29/2010WO2010045948A1 Isoquinolinone derivatives as nk3 antagonists
04/29/2010WO2010045900A1 A method for the preparation of dabigatran and its intermediates
04/29/2010WO2010020432A3 Compounds for treatment of duchenne muscular dystrophy
04/29/2010US20100105953 Human Adam-10 Inhibitors
04/29/2010US20100105915 Chemokine receptor binding heterocyclic compounds
04/29/2010US20100105914 Caspase inhibitors and uses thereof
04/29/2010US20100105905 EP2 Agonists
1 ... 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 ... 1080